跳至主要内容
临床试验/NCT00646334
NCT00646334已完成不适用

A Randomised, Multi-center, Prospective, Observer and Patient Blind Study to Evaluate AESCULAP Optilene® Mesh Elastic Versus Ethicon Ultrapro® Mesh in Incisional Hernia Repair

Aesculap AG12 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2006年6月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Aesculap AG
入组人数
80
试验地点
12
主要终点
Physical function score of the SF-36 questionnaire

研究概览

简要总结

Optilene® Mesh Elastic and Ultrapro® Mesh will be used for incisional hernia repair. The primary objective of this clinical study is to demonstrate that Optilene® Mesh Elastic is superior to Ultrapro® Mesh in incisional hernia repair in matter of the physical function score from the SF-36 questionnaire 21 days after mesh insertion. Secondary objectives include the patient's daily activity, the rating of patients pain and the wound assessment determined on several occasions during the six months observation time.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Female or male patients >=18 years
  • Female patients are incapable of pragnancy or must be using adequate contraception and are not in lactation
  • Patients wiht vertical aponeurotic incisions only
  • Incisional hernia with hernia size >= 3 cm
  • Patient is capable to understand and to follow the instructions
  • written informed consent
  • no mesh implantation at the same site during a previous operation
  • immune competence of patient

排除标准

  • Simultanous participation in an investigational drug or medical device study
  • Patients < 18 years old
  • Incisional Hernia withe a hernia size < 3 cm
  • Repair of an acute incarcerated hernia
  • Previous mesh repair at the same site
  • Patient with other than vertical aponeurotic incisions
  • Enterotomy to be performed during hernia repair at Surgery
  • Patient is on anti-coagulations-therapy
  • Patient is known or assessed to be non-compliant
  • Additional surgical treatment at the same time (e.g. cholecystectomy)
  • Immune incompetence of patient (e.g. chemotherapy)

研究组 & 干预措施

A

Experimental

Optilene® Mesh Elastic

干预措施: Mesh Implantation (Device)

B

Active Comparator

Ultrapro® Mesh

干预措施: Mesh Implantation (Device)

结局指标

主要结局

Physical function score of the SF-36 questionnaire

时间窗: 21 days after insertion

次要结局

  • wound assessment(6 months postoperatively)
  • patient's daily activity(6 months postoperatively)
  • physical function score from the SF-36 questionnaire(6 months postoperatively)
  • patient's pain(6 months postoperatively)

研究者

发起方
Aesculap AG
申办方类型
Industry
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验